Therefore, we propose that EA at acupoints exerts its neuroprotective effects against delayed infarct expansion and neurological deficits, at least partly, through the downregulation of S100B expression in the periinfarct area during the subacute phase of cerebral ischemia. Here, S100B is linked to brain ischemia.